Furthermore, it is important to note that oncological signaling pathways (VEGF/VEGF, STAT3, MEK1/2, etc.)have broad biological functions that could be difficult to target specifically or selectively in MSS CRC cells. This evidence concerns the gene VEGFA and colorectal carcinoma.